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SUMMARY
This work is concerned, with the measurement of calcium absorption
from the gut in healthy controls and in patients with diseases known to
be affected by, or to have an affect on, calcium absorption.
Among the factors which regulate normal gastro-intestinal calcium
absorption, current thought recognises calcium intake, vitamin D and
parathyroid hormone as playing an important part. It is well documented
that calcium absorption is reduced in states of malabsorption,
hypoparathyroidism and in patients with chronic renal failure, and
raised in hyperparathyroidism, urolithiasis and idiopathic hypercalciuria.
Difficulties inherent in classic calcium balance technices have
prompted a search for more practical and reliable methods of measuring
the degree of impairment of calcium absorption. Chapter I describes
the use of a chamber scintillation counter to precisely determine the
fractional absorption of radioactive ^Ca from the gut involving only
a few minutes of the patients time and obviating the need for hospitalis¬
ation in a metabolic ward. The effects of diet, calcium carrier load,
age and skin pigmentation on calcium absorption is discussed.
The application of this method to measuring calcium absorption in
patients with urolithiasis is detailed in Chapter 2. Of the group of
renal stone formers studied 82^ were found to be hyperabsorbers of
calcium. Recurrent stone formers showed a significantly greater
hyperabsorption of calcium than single stone formers and there was
better correlation in the recurrent cases with simultaneous calcium
excretion.
The role of sodium cellulose phosphate in the management of cases
of recurrent urolithiasis who exhibit calcium hyperabsorption is
4-
discussed in Chapter 3 and some of the factors affecting the efficacy
of this preparation are investigated.
It is shown that sodium cellulose phosphate can significantly
reduce the absorption of calcium from the intestine with concomitant
diminution of urinary calcium excretion. The plasma levels of other
divalent cations do not appear to be influenced.
Subsequent investigation in some of the patients exhibiting
calcium hyperabsorption, high urinary calcium and hypercalcaemia
showed them to have primary hyperparathyroidism. Measurements of
calcium absorption and other significant parameters in these patients
before and after sub-total parathyroidectomy are detailed in Chapter 4*
From these investigations it is evident that the main factor in
producing hyperealciuria and the renal stones in patients with normal
serum calcium, phosphorus and parathormone is a primary abnormality in
intestinal absorption resulting in calcium hyperabsorption. These
patients are readily differentiated from patients with 'resorptive'
hypercalciuria and renal stones due to hyperparathyroidism.
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7.
GENERAL INTRODUCTION
During the past decade, interest in calcium metabolism has greatly-
expanded and with current methods of measuring calcium absorption both
time consuming; and sequiring hospitalisation with atriot mataholio
regimen, a simple more direct method would be of great advantage.
Measurement of serum calcium alone will only give the equilibrium
figure between calcium inpdt into the bloodstream (net absorption and
bone resorption) and calcium output (bone mineralisation, renal
excretion and intestinal secretion) at the time of measurement and
will not necessarily reflect quite large changes in any one of these
parameters. For example, the concept that there exists a 'steady
state' or physio-chemical equilibrium between blood and bone calcium,
the level of which is determined by parathyroid activity, is not
supported by recent work(Nordin and Peacock, 1969)•
Abnormalities of gastro-intestinal absorption of calcium are well
recognised features in many disorders of calcium metabolism thus accurate
in vivo measurement of absorption will of necessity lead to a greater
understanding of the cause and effect of these abnormalities than in
vitro measurements of serum and urinary calcium alone.
The mechanism for the increased urinary excretion of calcium in
patients with hypercalciuria has not yet been established. Henneman
et al (1958) believe that the possible sequence of events, leading to
idiopathic hypercalciuria was 'Pyelonephritis, tubular damage, decreased
reabsorption of calcium, hypercalciuria, tendency to hypocalcaemia,
compensatory parathyroid hyperplasia, hyperphosphaturia and finally
hypophosphataemia'. They suggested that if such a sequence of events
could be proven the syndrome could be termed 'primary renal tubular
hypercalciuria'. This view, that the primary defect was one of tubular
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handling of calcium, has been supported by other workers in independent
studies (Jackson and Doncaster, 1959? Edwards and Hodgkinson, 1965).
More recent work however by Peacock and Nordin (1968) has shown that
tubular reabsorption of calcium in patients with hypercalciuria was
the same as that in subjects with normal urinary calcium. They found
that 'tubular reabsorption of calcium' in hypercalciurics was similar
to that in patients with nephrolithiasis and in normal subjects, they
concluded that the increased urinary excretion of calcium in most cases
of 'idiopathic hypercalciuria' must be due to an increased filtered
load of calcium.
Wills et aL 1970 suggest that "Calcium is excreted by the kidneys
through a combination of filtration and tubular reabsorption of the
diffusable fraction of the serum calcium. Normally 95-99^ of the
filtered calcium is reabsorbed. Thus a 5^ increase in the glomerular
filtration rate, without change in tubular reabsorption, could cause
a four-to-five fold increase in calcium excretion; similarly a 5fo
change in reabsorption could cause a six-fold change in urinary excretion
(Kleeman et al). Thus a very small change in the diffusable serum
calcium fraction following gastro-intestinal absorption could, by
increasing the filtered load account for hypercalciuria". This is surely
too facile an explanation as it is only true if the tubular reabsorption
remains constant in absolute terms rather than as a percentage.
In the 125 cases of urolithiasis studied in this work 82/£ were
found to be hyperabsorbers of calcium. Recurrent stone formers showed
a significantly greater hyperabsorption of calcium than single stone
formers. There was also better correlation in the recurrent cases
between hyperabsorption and hypercalciuria.
The link between hyperabsorption of calcium and hypercalciuria
in the formation of renal stone lies, to my mind, in the increase in
the filtered load of calcium in the nephron following hyperabsorption
of calcium due to an inherent metabolic abnormality. Calcium in
excess is known to be a cell toxin and, as detailed in Chapter 2, stone
formation may be subsequent to an extruded calcified tubular cell
acting as a nidus for crystallisation. The 'inherent metabolic
abnormality' giving rise to intestinal hyperabsorption of calcium has
at the moment not been determined but I strongly suspect that it is
partly involved with the metabolism of refined carbohydrates in modern
diet and preliminary investigations by us in this area are encouraging.
There are now a number of ways by which urinary calcium can be
reduced. High fluid intake may be recommended for all stone formers
as a basic protective measure. A low calcium diet of less than 50 mg
daily should provide an effective reduction in urinary calcium (Nordin,
1972) but due to the presence of calcium in so many kinds of food and
in drinking water, such a diet is hardly possible. It is unpalatable,
lacks many essential trace elements and requires a considerable amount
of will-power on the part of the patient to maintain it consistently.
In such a situation, cellulose phosphate, an ion exchange cellulose with
a particular affinity for calcium has certain advantages. In the
stomach it exchanges sodium for calcium which is bound to the cellulose
and eliminated in the faeces thus preventing the absorption of dietary
calcium. Part of this work shows the effect of cellulose phosphate on
intestinal calcium absorption and the short and long term effect on
certain other essential divalent cations.
Although the importance of vitamin D in the regulation of gastro¬
intestinal calcium absorption is universally recognised (Nicolayson,
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Feg-Larsen and Malm, 1953) > "the exact role for parathyroid hormone in
the absorption of calcium from the gastro-intestinal tract had been
largely assumed from indirect evidence derived from clinical states
associated with abnormal parathyroid activity. Will3 et al. (1970)
attempted to define such a role and showed in normal subjects, and one
patient with idiopathic hypoparathyroidism, treated with parathyroid
extract that "In all subjects there was a small increase in the gastro¬
intestinal absorption of calcium during the administration of
parathyroid extract". From this they deduced that parathyroid hormone
plays a "small and significant role in enhancing the gastro-intestinal
absorption of calcium in man". Previous studies (Albright et al. 1929;
Aub et al. 1937) had failed to detect this effect because faecal
calcium excretion was used to determine calcium absorption in the
classical way. It is probable that faecal calcium excretion does not
give a true estimate of intestinal calcium absorption in a situation
where the serum calcium concentration is changing, as it does with
administration of parathyroid extract. In such a situation the increase
in serum calcium concentration could induce an increase in endogenous
faecal calcium. If the extra calcium is secreted into the intestinal
tract at a point lower than the absorption site, any changes in
absorption would be masked.
The use of an external scintillation counting technique to measure
calcium absorption, as detailed in this work, has overcome this problem
for it provides a direct measurement of the total absorbed calcium
load. Measurements detailed in Chapter 4 support the views of Wills et
al, discussed above, on the significance of parathormone in calcium
absorption, and provide a method for differentiating between the




THE APPLICATION OF AN EXTERNAL ISOTOPE COUNTING TECHNIQUE
IN THE MEASUREMENT OF CALCIUM ABSORPTICN
1.1 Introduction
Radionuclides of calcium have been used in an attempt to measure
the absorption of calcium from the gastro-intestinal tract since
Garner (i960) and his associates measured the fractional excretion in
45
urine of ^ Ca after administering two doses of radioactive calcium,
one given intravenously and the other by mouth. The absorbed fraction
45
of the Ca was then calculated by assuming that the fractional
excretion of the absorbed part of the oral dose is identical to that of
the entire intravenous dose. This method was later developed by
Degrazie et al. (1965), Bronner (1962) and Dellipiani, Tothill and
Girdwood (1964)* using either the same technique or modifying it by
giving two radionuclides, ^Ca and ^Ca, at the same time.
Although these workers based their calculation on measurements of
the amount of activity excreted in the urine, an equally valid
calculation can be based on measurements made of activity present in
blood or in any other body calcium pool, so long as the assumption
of identical distribution of the intravenous dose and the absorbed
part of the oral dose holds.
In 1964 Lutwak and Shapiro described a technique for measuring
calcium absorption in man using a large volume liquid scintillation
counter to count forearm radioactivity after an oral dose of ^Ca.
This technique, however, uses only a single oral dose and because
factors other than absorption influence arm radioactivity their
calculations are based on assumptions that are uncertain.
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With the advent of large volume chamber scintillation counters a
much more accurate and exact technique, again based on the assumption
that the distribution in the body of an absorbed part of an oral dose
is identical to that of an entire intravenous dose, has become available
(Curtis, Fellows and Rich, 1967» Wills et al. 1970 > Macleod, 197l)»
The method described in this work measures the fraction of a known
intravenous dose of ^Ca in the forearm and assumes that this will be
the same as that of the absorbed part of an oral dose. Knowing the
exact amount of the radionuclide given orally it is then easy to
calculate the exact amount absorbed from the gut.
In an effort to check the validity of this method it was compared
with an independent measure of uptake of the oral dose by stool
counting.
1.2 Materials and Method
Twenty male control subjects were selected who had no evident
disorder of calcium metabolism or intestinal function and who were all
on a normal diet at the time of investigation. The radionuclide used
was ^Ca, a 1.31 MeV gamma emitter with a 4*53 day half life. The
forearm being relatively small and freely mobile is especially suited
to external counting and was used in all measurements. In all subjects
preliminary serum calcium and 24-hour urinary calcium measurements
were made. (Table 1 .l).
The apparatus used to carry out arm activity measurements comprised
a large volume lead chamber, constructed to my design by J & P Engineering,
Reading, incorporating two separate Nal (Tl) 4-inch scintillation
crystals in opposition with a rubber coated arm rest and hand grip
between them to ensure constant geometry when counting the forearm on
13.
subsequent days. (See Plates I, II and III).
Counts were recorded on an Ortec timer/sealer, incorporated in a
standard NHS modules bin, the output being measured by covering the
1.3 MeV photopsak of ^Ca in order to rejaot the low energy contribution
of ^Sc. Standards were used to check the calibration of the counter
at each measurement.
Preliminary studies with four of the subjects established that it
took approximately 20-hours for the effective decay of 1^uCi intravenous
dose of ^CaClg to become exponential in the tissues, bone and blood.
This was achieved by serial counting of the forearm at one-hourly
intervals and plotting the subsequent curves. All the curves obtained
differed little in appearance and were essentially biphasic. The first
8-nours showed a step appearance and exhibited a 'plateau' effect from
2-6 hours followed by a reduction in activity which became exponential
at about 20-hours.
In all subjects measured in this way the 24-hour point lay on the
exponential part of the decay curve and was thus selected as a suitable
time at which to measure arm activity. The compound curve for these
four subjects is shown in Figure 1.1 without correction for physical
decay.
In order to ascertain the time taken by the absorbed fraction of an
oral dose to reach a similar equilibrium in the forearm, four further
subjects were each given an oral dose of lOyuCi ^7CaCl2 in 100 mg
calcium gluconate carrier solution made up to 100 ml with water to
drink on a fasting stomach. Serial arm counts were obtained in a
similar manner to that used for the measurement of the intravenous dose.
„er scintillation counter usedPlate 1.1. »eetjS'=5M'
Plate 1.2. Shielded crystals and arm rest from the front port
used for inserting the arm.
Plate 1.3. Crystals and arm rest from the normally closed port
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FIG 1.1 Mean 47Ca effective decay ± S.D. in the forearm followi
I.V. injection of 1 pci 47CaCl2 in four control subjects.
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The resultant curves obtained showed that, on average, 20-hours were
required for the curve to become exponential in the tissues of the
forearm following absorption of the absorbed part of the oral dose from
the intestine in the fasting state. (See Figure 1.2). Absorption of
the absorbed fraction of the oral dose is complete by 2 hours in a
fasting stomach. (Degrazie et al. 1965; Avioli et al. 1965) and this
is supported by the initial part of the curve (Figure 1.2).
Having obtained these two necessary parameters all the subjects
had their calcium absorption measured in the following manner.
On Day 1, each subject was given about lyuCi ^CaClg in 1 ml. saline
intravenously, the exact volume administered being determined by weighing.
On Day 2, 24-hours after the injection, the background count rate was
measured with the subject in position beside the chamber but with his
arm outside. (Plate 4).
Following this, the forearm was inserted into the chamber and
counted for 100 seconds (Plate 5)*
On completion each subject was given to drink about 10yuCi ^CaClg
in 100 mg calcium gluconate solution made up to 100 mis with water.
Subjects fasted at least 12 hours before and 2 hours after this dose.
On Day 3> background count rate and arm count rate were measured again,
on this occasion 26 hours after the oral dose on Day 2, the additional
2 hours being the time taken for full absorption of the absorbed part
of the oral dose (see Figure 1.2).
A similar final measurement was made on Day 4> 52 hours after the
oral dose in order to establish a biological decay factor.
Plate 1.4» Subject in position for background counting.
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FIG 1.2 Mean effective 47Ca. decay in the forearm following
10 Mci 47CaCl2 oral dose in four subjects.
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Calculations
Arm count rate corrected for body background and decay was expressed
as arm activity (C) measured at 24 hours after injection (C^), 26 hours
aftes? the oral deao (a2) and 52 hau3?e after the aral doae (0^). Thus
at 24 hours the fractional arm accumulation (C^) of the intravenous
dose (i.V) was ^1^
TiW
At 50 hours the fractional arm accumulation (Og) of "the absorbed
fraction (p) of the oral dose (0) was ^1^ X (p) X (0) plus the
(i.v)
residual activity from the intravenous dose expressed as (C^).(b) where
(b) equals the biological decay factor for the 26 hour period since the
measurement of (C^).
ie. (C ) = C1 XFXO + C XB
I.V.
Thus the absorbed fraction of the oral dose is:
(F) . (C2 - * B x I.V)
0X0
The biological decay factor (b) was determined by measuring arm
activity at the end of a further 26 hours (C^) and, assuming (b) is not
Q
time dependent, then B = .
°2
Substituting and simplifying gives the expression:
f . Sfa - fi? x iv
(°1 °
In order to check the validity of the method and to ascertain to
some degree, the accuracy of the measurements made of fractional calcium
absorption, four of the control subjects had concomitant conventional
stool counts carried out as an independent measure of body incorporation
of 47Ca.
On the night before the oral dose of 47CaCl2 a standard dose of
23.;,
carmine marker was given and stool collections were started on the
appearance of the carmine and continued until all the carmine had
passed (this took about 4-5 days).
The stools were collected as a single pooled specimen for each
subject and liquidised. These were then counted in the large volume
chamber used for arm counting, a special aperture in the top of the
chamber being included by the manufacturers j. & P. Engineering,
Reading, especially for the counting of 24 hour urine and faecal
samples (Plate 6). The results were then compared with standards of
similar volume and consistency.
The fraction of the oral dose incorporated in the body (a) was
calculated from:
4=1 -(fraction of oral dose of ^Ca recovered in stool)
and the results compared with those obtained by arm counting.
1.3 Results
The results obtained from these control subjects gave parameters
of ^Ca absorption from the intestine which ranged between 25 and 36
per cent of the oral dose with a mean of 30 per cent. In all of the
subjects measurements of serum calcium and 24 hour urinary calcium were
within normal limits (Table l.l).
The comparison between the percentage calcium absorption obtained
by arm counting and the absorption calculated from stool recovery in
the four subjects studied is shown in Table 1.2.
The mean absorption obtained by stool counting, although not
significantly different from that obtained by arm counting is slightly
less as would be expected due to re-excretion of part of the absorbed
fraction by the lower colon.
24.
TABLE 1.1
^Ga absorption in control cases












R.M. 32$ 10.32 245
I.L. 3cyfo 29/o 36$ 9.84 195
H.G. 28$ 10.20 188
D.M. 30$ 9.95 220
R.L. 26$ 30$ 10.15 240
P.C. 28$ 9.75 180
R.C. 26% 10.35 200
D.S. 2% 36$ IO.43 220
P.B. 2% 27$ 26$ 9.90 194
P.G. 31$ 29$ 10.10 185
B.G. 3% 9.84 210
D.J. 36$ 9.95 180
S.D. 36$ 10.23 180
H.P. ON 9.84 195
N.S. 3% 9.78 200
P.L. 35$ 10.14 215
J.S. 26$ 10.23 194
A.K. 25$ 9.85 175








Comparison between ^Ca absorption as
measured by arm counting and stool recovery








Plate 1.6. Counting of 24 hour urine and faecal samples.
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In order to check the variation, if any, of ^Ca absorption with
time, measurements were repeated over a period of two years in those
subjects who were available.
These remained remarkably oonsiatent as oan be seen from Table 1.1.
The mean age of these control subjects was 32 years and is
comparable with the mean age of the single stone formers (31 years) and
recurrent stone formers (34 years) studied in Chapter 2.
1.4 The effect of diet and calcium carrier load on absorption
All the control subjects were on a normal diet at the time of
investigation and it was stipulated that they had to be fasting 12 hours
before and 2 hours after the oral dose because the two main factors
which would obviously affect the absorption of calcium from the gut
were:
a. Pre-existing diet
b. Carrier load of stable calcium
a. Pre-existing diet
It has been shown by Holm (1958) that calcium absorption is
affected by the pre-existing diet in that patients on long-term
balance studies showed an increase in calcium absorption as an
adaptation to a low calcium intake. Similarly it has been reported
for rats that the small intestine responds to a low calcium diet
by increasing the active transport of calcium (Kimberg, Schachter
and Schenken, 196l).
From this it is obvious that to achieve accuracy in measuring
and postulating a normal range of calcium absorption the pre¬
existing dietary pattern of both controls and patients must be
28.
known and. appropriate corrections made for those on a long-term
low calcium diet.
b. Carrier load of stable calcium
In six of the control subjects the effect of varying the amount
of the calcium gluconate carrier was studied.
Carrier loads of calcium gluconate varying from 10 mg to
1000 mg were given with the oral dose of ^CaCl^ and the percentage
calcium absorption measured by forearm counting. The results
detailed in Table 1.3 show that the percentage calcium absorption,
as estimated by this technique, varied inversely with the stable
calcium carrier load. (Figure 1.3).
In non-fasting subjects it can be readily seen that the presence
j |
of exchangeable Ca ions in food in the intestines at the time of the
oral dose would affect the amount of physical carrier available and in
addition other substances such as phytic acid and phytates would
readily bind with free ^Ca++ rendering it insoluble and unabsorbable.
1.5 The effect of age and skin pigmentation on absorption
In the few young men we have investigated for urolithiasis we found
that their calcium absorption was much higher than was expected. In all
of these the epiphyses had not closed. On repeating the measurements with
several 'young' controls whose epiphyses, on the evidence of their
compulsory annual X-ray, had not closed, they consistently showed a
normal range of absorption much higher than that obtained in 'adult' men
(see Table 1.4)» and thus by definition the control subjects used in
Table 1.1 were all over the age of 20 years.
Again we have collected substantial evidence and are at the moment
TABLE 1.3
Percentage calcium absorption for various calcium
gluconate carrier loads with mean absorption - SD
<fo Calcium Abs. with differing calcium
„ , . , carrier loads
Subject
10 mg 100 mg 500 mg 1000 mg
I.L. 70 30 24. 20
P.G. 65 31 19 16
B.C. 75 35 18 19
D.M. 58 30 25 17
R.L. 55 26 20 15
R.C. 66 26 17 15
Mean
Abs. 65-8 30 t 3 20-3 17-2
FIG 1.3 Mean percentage calcium absorption ± S.D. compared
with calcium gluconate carrier load in mg.
31
TABLE 1.4
Percentage calcium absorption, serum calcium and 24-bour
urinary calcium in patients and controls in whom the
epiphyses had not closed at the time of measurement
Serum
Subject Age Diagnosis Calcium
mg/lOOml
°/o Calcium Abs. 24-hr uaexcretion mg
K.W. 17 Ureteric Colic 10.35 53 250
D.J.Y. 17 Ureteric Colic 9.28 50 198
P.S. 16 Renal Colic 10.20 54 220
C.M.J. 19 Renal Colic 10.32 54 245
B.M. 18 Control 9.92 52 170
P.P. 17 Control 10.34 32 180
P.A. 18 Control 10.32 44 212
P.S. 19 Control 9.84 44 200
C.D. 18 Control 9.56 44 180
W.P.N. 19 Control 10.45 45 240
M.N.S. 18 Control 10.35 53 210
W.D.J. 18 Control IO.42 54 215
S.K. 18 Control 9.73 28 175
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conducting an investigation into the effect of skin pigmentation on
calcium absorption. Since we began to use this technique we have seen
8 negro and Indian patients referred for uro-genital investigations.
It was noted that their caloium absorptions were usually in or below
the 'normal' range and subsequent measurements on 'black* controls
verified this. The preliminary results are presented in Tables 1.5 and
1.6.
1.6 Discussion
The principle advantage which recommends this external counting
method of measuring calcium absorption is its simplicity. Uncertainty
regarding complete stool and urine collection and accuracy of the
meticulous laboratory techniques is avoided and the patient is not
embarrassed or inconvenienced. It also avoids the inaccuracy introduced
in the stool collection method by the excretion of previously absorbed
calcium by the lower colon. Sources of error inherent in the technique
lie in the prior assumptions and the experimental conditions obtained.
Several theoretical factors should be considered in interpreting
the results of this method. After oral administration of ^CaCl^ the
rate of uptake of isotope into the forearm is a complex function of
continually changing input into blood with varying rates of uptake by
the forearm thus differing from the intravenous dose after which the
forearm activity reflects uptake from a single instantaneous input.
The ratio of forearm activities, oral to intravenous, therefore does
not give a precise estimate of calcium absorption. Nevertheless the
results show that this ratio of forearm activities does in fact reflect
mainly the gastro-intestinal absorption of calcium.
It is assumed that the oral dose is promptly absorbed 2 hours
33.
TABLE 1.5
Percentage calcium absorption, serum calcium and.





Calcium mg <fo Calcium Absorption
C.C. 19* 10.24 195 29
S.B.S. 22 9.82 205 29
S.S.H. 18* 10.00 210 31
P.R.R. 29 9.72 185 20
R.B. 20 9.85 195 17
H.H. 21 10.20 208 23
* Epiphyses not closed
34
TABLE 1.6
Percentage calcium absorption, serum calcium and 24-bour
urinary calcium in black-skinned patients with urolithiasis
, . , . Serum Calcium 24-hr Urinary ^ .Subject Age /. . n i • 1° Calcium AbsorptionJ & mg/100 ml Calcium mg '
N.J. 23 10.23 240 45
C.L. 41 9.74 215 24
B.J. 42 10.15 230 28
A rJ . 27 9.85 198 27
C.A. 23 9.75 210 35
P.A. 33 10.10 195 28




after administration and reaches equilibrium in the tissues of the
forearm by 18-20 hours. This is largely demonstrated in Figure 1.2,
and there is ample evidence by other workers that in a fasting subject,
under the conditions of the test, absorption is rapid and essentially
complete in 2 hours (Legrazie et al. 19&5; Avioli et al. 1965).
Furthermore, the rate of change of arm activity becomes relatively slow
20 hours after administration of radio calcium (see Figure 1.2) and
accordingly errors introduced by an incorrect estimation of the time of
absorption will be small.
A correction for residual arm activity from the intravenous dose
must be made at the time of measuring forearm activity following the
oral dose and this is done by estimating the biological decay factor
as explained in the calculations.
There is a considerable amount of isotope remaining in the gut
at the time of counting 26 and 50 hours after the oral dose, but, with
correct positioning of the patient in relation to the counting chamber,
ie. to the side and close against the lead wall so that no part of the
body is seen through the port by the detectors, and careful background
counting the effect of this surplus radioactivity in the gut can be
minimised.
Other factors which became increasingly evident after 2 to 3 years
A
experience with the technique is that the normal range of 25-35/6
absorption of the oral dose does not apply to those in whom the
ephiphyses have not closed and to those who have heavily pigmented skins.
In young men with actively growing bone the amount of calcium
required to lay down new osseus tissue is obviously met by greater
calcium absorption than is seen in those in whom growth has stopped.
This is reflected in the higher 'normal1 range of absorption seen by
us in young men controls. These were measured subsequent to our
suspicions being raised by abnormally high calcium absorption seen in
two young sailors referred for urologioal investigation with renal
stone.
In the case of those of Negro and Indian descent and a below 'normal'
calcium absorption, an interesting theory is that their heavily pigmented
skins which provides protection against the large dose of ultra-violet
light experienced in the tropics where prolonged sunshine is common, is
too effective a barrier for the moderate amount of sunshine found in
these isles. This would interfere with the ultra-violet light -
calciferol - Vitamin D reaction and we are at present looking at controls
exposed to varying doses of ultra-violet light before taking the oral
dose of calcium.
The results to date are most encouraging showing increases in
calcium absorption of 1.5 to 2 times over normal following 10 minute doses
of ultra-violet light.
Obviously then, the questions of ephiphysial closure and skin
pigmentation must be considered when using this technique and a better
understanding of the factors involved will, I hope, be the outcome of
the present study.
CHAPTER 2
THE MEASUREMENT OF CALCIUM ABSORPTION IN UROLITHIASIS
2.1 Introduction
The abundant research already done on urolithiasis has clearly
shown that stone formation in any one case is a result of a number of
abnormal conditions. These include abnormalities of the calyceal
system and pelvi-ureteric out-flow of urine which result in stasis
and, more commonly, abnormalities of the urine itself. Infection is
now uncommon in Western communities as an initiating factor in urinary
tract stone.
Of the urinary abnormalities, the presence of excessive amounts of
calcium, or other stone constituents, and the relative lack in the
urine of substances which inhibit precipitation of calcium salts have
been two of the most promising lines of further research.
An association between hypercalciuria and calcium urolithiasis
was described by Flocks in 1939 but subsequent work has fallen short
of establishing the relationship between these two phenomena. If
hypercalciuria is defined as the excretion of more than 300mg of
calcium in 24-hours in the male and more than 250mg of calcium in
24-hours in the female Hodgkinson and Pyrah,(1958) about 8 per cent
of the general population are hypercalciuric. In a group of patients
forming calcium containing renal stones, Melick and Henneman (1958)
found that 32 per cent had hypercalciuria. Similar findings have been
made by Hodgkinson and Pyrah (1958), Boyce et al. (1958), Harrison
(1959) and Litin et al. (l96l). Whilst an excessive urinary calcium
is present in other specific diseases, hypercalciuria occurring in the
absence of any of these was described by Albright et al. in 1953. This
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syndrome was defined as the occurrence of a high urinary calcium in
association with normal serum calcium, a tendency to hypophosphatemia
and renal stone formation and it has been recognised by others
(Henneman et al. 1958; Harrison, 1959; Parfitt et al. 19&4 ant^
Edwards and Hodgkinson, 1965). There are several possible causes of
this hypercalciuria but Cannigia, Gennari and Cesari (1965) suggested
that it was primarily absorptive in origin. Peacock, Hodgkinson and
Nordin (1967) showed the importance of dietary calcium in demonstrating
hyperealciuria, suggesting that the hypercalciuria in stone formers
was probably due to excessive absorption of calcium thus implying that
idiopathic stone formers were largely drawn from that segment of the
population in whom absorption and therefore urinary excretion of calcium
was above average.
The role of enhanced gastro-intestinal absorption in the aetiology
of renal stone formation however, has been questioned. Whereas some
workers have reported that urinary calcium excretion could be reduced
with a low calcium diet (Henneman et al. 1958; Harrison, 1959: Gill
and Bartter, 1961; Dent and Watson, 1965; Peacock, Hodgkinson and
Nordin, 1967) others have indicated that it did not change (Jackson
and Doncaster, 1959; Edwards and Hodgkinson, 1965; Phillips and
Cooke, 1967). This apparent discrepancy was probably due to inadequate
restriction of dietary calcium in the second group as the case reported
by Dent and Watson (1965) did not have a satisfactory reduction in
hypercalciuria until distilled water was used for both drinking and
cooking. The conclusion reached by these authors was that the primary
defect in hypercalciuria could be due to the inability of the intestinal
mucosa to limit absorption in the usual way, resulting in excessive
calcium absorption. The results reported in this Chapter would tend
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to support this view and suggest that a primary defect in the handling
of calcium by the intestine plays a crucial part in the increased
urinary calcium excretion seen in patients with renal stones and
hyperealciuria. This handling defect probably causes small but significant
increases in the diffusable serum calcium fraction which results in a
significant increase in the filtered calcium load and hence an
increased tendency to for* calcium containing renal stones.
2.2 Materials and Methods
This Chapter is concerned with the study of a group of stone formers
and recurrent stone formers in the Royal Navy and the purpose of the
investigation was to establish the incidence of hypercalciuria in these
two groups and its relationship to intestinal calcium absorption
measured by arm counting as detailed in Chapter 1.
All cases of urolithiasis studied were registered in the Renal
Stone Survey which is supported by grant from the Medical Research Council
and all were either in or out-patients in the Department of Urology of
the Royal Naval Hospital, Haslar.
Initially, each patient had a full general and metabolic investigation
including excretion urography. The serum calcium, inorganic phosphate,
protein and alkaline phosphatase were estimated on at least 4 sepa. .
occasions with the patient in the fasting state. Serum calcium was
estimated by the method of Keffler and Wolfman, (1964) adapted for
autoanalyser, and the upper limit of normal for this laboratory was
taken as 10.5mg per 100 ml.
Urinary calcium excretion was measured first of all with the patient
on a diet containing calcium supplements since it has been established
that hypercalciuria is only detectable at moderately high calcium
1
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intakes (Peacock, Hodgkinson and Nordin, 1967). Thereafter a low
calcium diet (l50mg calcium per day) was given and, after a period of
three days, further measurements of calcium excretion were made to
establish the response to this. Urinary oaloium was estimated by
atomic absorption flame photometry using a Unicam SP.90.
Gastro-intestinal absorption of calcium was measured by the arm
counting technique described in Chapter 1.
Since it has been reported that restriction of calcium intake,
eg. low calcium diet, will result in an increased absorption of available
calcium from the gut (Malm, 1958; Kimberg, Schachter and Schenken, 19&1)
all the patients prior to January 1972 were on a normal diet except for
a fast of 12 hours before receiving the oral dose of ^CaCl^ on the
second day of the test. For various reasons during 1972, 49 of 83
patients so tested had started a low calcium diet of 150mg of calcium
daily at the time of the investigation. Of these, the great majority
had calcium absorption measured within a day or two of starting the low
calcium diet and in no case was the measurement made with the patirtnt
more than 5 days on this diet. Comparing the two groups, the results
showed no statistical difference; 63 per cent of patients on the low
calcium diet and 60 per cent of the patients on a normal diet were
absorbing calcium excessively. This suggests that a low calcium diet
for a short period of time doe3 not influence the process of absorption
from the gut. This observation agrees with that of Wills et al. (1970).
2.3 Results
125 case3 of urolithiasis were studied and only 2 of this number
were female.
Of the 125 patients, 23 (18 per cent) absorbed calcium within the
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normal range; 102 (82 per cent) absorbed, it excessively. The extent
of this hyperabsorption of calcium was variable and is shown graphically
in Figure 2.1.
Estimations wora repeated in a number of these patients over an
18 month period and these showed that the tendency to absorb calcium
excessively remained although there was some variation of the extent
of this. (Table 2.1).
A comparison of calcium absorption with 24 hour urinary calcium
excretion in the 125 patients showed that all but three who were hyper-
calciuric were also absorbing calcium excessively from the intestine.
(Figure 2.2).
This confirms observations by others (Flocks, 1939; Zisman, Pak
and Batter, 1967; Wills et al. 1970)•
Two sub groups were formed from the series for comparison. The
first was of patients who had formed only a single stone at the time of
investigation. The second group comprised those who had formed 2 or
more stones in clearly separated instances and were therefore recurrent
stone formers. The first group may represent the type of patient in
whom stone formation is an isolated incident but it is recognised that
with a sufficiently long follow-up period some of these could have
recurrences at a later date. In other aspects both groups appeared
to be v/ell matched; the mean age of the single stone formers was
31 years and that of the recurrent stone formers 34 years. The
difference in mean age was not significant.
Of 78 cases of apparently solitary stone, 59 (76 per cent) showed
excessive calcium absorption and 31 (40 per cent) of these were
hypercalciuric. Of 47 cases of recurrent stone 42 (89 per cent)
36
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FIGURE 2.1 Variable intestinal hyperabsorption of 47 Ca
in 125 cases of urolithiasis.
TABLE 2.1
Repeat estimations of ^Ca absorption
on known hyperabsorbers
Patient ^Ca Absorption
T.G.H. 16.11.70 74/" 13.9.71 60/
E.J.H. 16.11.70 64/ 13.9.71 51/
P.J.D. 14.12.70 76/0 19.6.72 52/
B.L.P. 10. 5.71 77/ 19.7.71 71/
H.J.T. 7. 9.70 44/ 19.7.71 41/
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FIGURE 2.2 Comparison of 47 Ca absorption with 24 hour
urinary calcium excretion in 125 cases of
urolithiasis.
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absorbed calcium excessively and of these, 36 (77 per cent) were
hypercalciuric (Table 2.2).
In the single stone formers the mean calcium absorption was 46 per
cent (SB.13) and the mean 24 haur urinary oaleium excretion was 2J6 mg.
(3D.116). In the recurrent group, mean absorption was 56 per cent
(SD.l6) and mean excretion, 345 nig. (SD.IO4). The comparison between
the two groups shows a significant difference. (Chi - squared test to
one degree of freedom P 0.025) even with the probability of
"contamination" of the first group by a number of potential recurrent
stone formers (Table 2.3).
2.4 Discussion
The incidence of hypercalciuria in all patients referred with
renal stone to the Department of Urology in this hospital is approxi¬
mately 33 per cent. Of the 125 cases of urolithiasis investigated in
this study 54 per cent were found to have hypercalciuria but this is
likely to be an artificially high figure in that the recurrent stone
former will tend to be referred for complete hospital investigation
more often than the patient with a single, short-lived incident.
Excessive urinary calcium excretion has been ascribed to excessive
intestinal calcium absorption (Harrison,•1959, Parfitt et al. 1964;
Peacock et al. 1967) and the results from these ^Ca absorption
studies support this concept and confirm that a majority of stone
formers, whether they are hypercalciuric or not, absorb calcium
excessively from the intestine and this is most obvious in cases of
recurrent urolithiasis.
It is apparent from the results that there is only a partial
correlation between apparently excessive calcium absorption and the
occurrence of hypercalciuria. All but three of the hypercalciurics
TABLE 2.2
Comparative incidence of increased ^Ca absorption and
hypercalciuria in solitary and recurrent stone cases
^Ca Absorption Urinary Ca++
Excretion
1
3e?o < 300 rag/day
Solitary
Stone 78 59 (Wo) 31 (40$
Recurrent
Stone 47 42 (89$ 36 (77$
TABLE 2.3
Comparison of mean absorption and urinary calcium
excretion in solitary and recurrent stone formers
)
Mean ^Ca Mean Urinary
Absorption Ca++ Excretion
Solitary Stone w° 276 mgm/day
(SD.13) (SB.116)
Recurrent Stone 56/0 346 mgm/day
(SB.16) (SB.104)
p 0.025
were found, to absorb calcium excessively but 49 patients who were
absorbing calcium in excess from the gut were excreting calcium in
normal amounts in the urine at the time of the test. Since the ^ Ca
absorption measurement deals only with the percentage absorption of
an oral calcium load it is possible that the high absorption figure
and normal excretion was due to a low calcium intake prior to the test.
411 patients, however, were on a standard ward diet at the time with
calcium supplement in the form of a pint of milk per day over and
above that taken with cereal, tea and coffee. In the circumstances
if there was a simple- linear relationship between calcium uptake and
excretion, greater correlation might have been anticipated. Again
urinary calcium excretion is dependent on accuracy of urine collection
and it is conceded that in some cases collections might not have been
complete. However, since hypercalciuria is assessed on the amount of
calcium in a 24 hour collection of urine, diurnal variations of calcium
concentration will be concealed and hypercalciuria of varying degree may
occur on a number of occasions within a 24 hour period without there
being necessary overall hypercalciuxia (Marshall and Barry, 1972). It
may therefore be inadequate to define hypercalciuria as the excretion
of more than 300 mg of calcium in 24 hours in the male and 250 mg in the
female (Hodgkinson and Pyrah, 1958)* Hose (1967) has pointed out that
the normal range of urinary calcium varies from one country to another
and may also vary within a country. Watson and Dale (1966) consider
that in London the excretion of up to 400 mgms of calcium per day is
normal for a man and 300 mgms per day for a woman.
In the series of patients studied here, however, there appears to
be closer correlation between intestinal calcium absorption and urinary
calcium excretion in the recurrent than in the apparently solitary
stone formers. If dietary differences and possible errors in urine
collection are excluded, this suggests that in the latter, calcium is
deposited, or stored temporarily after absorption, prior to being
excreted at a later date.
An implication of finding an increased absorption of calcium in a
high proportion of cases of urolithiasis is that greater quantities
of calcium are being presented to the excretory system, and the nephron
in particular, for excretion. Calcium is a known potential toxic
agent when present in excess within the body and cellular damage due
to high local concentrations of calcium might be anticipated in the
cells of the nephron or its interstitiol tissues. This might be the
interpretation of the findings by Anderson (1968) of foci of calcium
phosphate precipitation in the kidneys of patients with recurrent
metabolic stone. Similar foci were present in patients who had no
history of stone formation but they were significantly more prevalent
in the stone forming group. The calcium phosphate was present within
the interstitial tissues and the epithelial cells of the renal tubules,
sometimes extending into the lumen. He found the loop of Henle and the
collecting tubules most frequently involved. Boyce (1972), in a study
of biopsies of human kidney, has shown accumulations of calcium
deposition within the lumen of the nephron and considered that the
origins of this material were in the proximal renal tubules and that
there was subsequent migration to the collecting ducts. He attributed
the high incidence of medullary concretions to the coalescing ductal
anatomy. Cook (1972) in a radioisotope study demonstrated a marked
calcium concentration gradient ranging from maximal in the papilla tip
to minimal in the kidney cortex. Most significantly, hov/ever, he was
able to demonstrate differences in the calcium content of anatomically
comparable regions of the kidney when he compared specimens from
populations with and without a tendency to form renal stones.
It is well known that calcium salts tend to be deposited in tissue
which are already the seat of injury or damage or in tissues which are
undergoing degeneration. Scarparelli (i960), in drawing attention to
this, pointed out that the cause of damage in some cases could be an
excess of calcium itself. Cells, such as those in the nephron, which
are involved in the metabolism or transport of calcium are probably
protected against its toxic effects within certain limits. An excess
of calcium, however, may overwhelm the protective mechanism and result
in tissue damage and subsequent calcium deposition.
The lesions described by Anderson (1968) and others may, therefore
be primary and stone formation, in the tubules and calyces, a secondary
phenomenon due to crystalisation on a calcified nidus extruded from
the epithelium of the tubules. These lesions may thus be a direct
consequence of a metabolic abnormality resulting in increased
intestinal absorption of calcium as has been found in such a high
proportion of this series of stone formers. What the nature of this
metabolic abnormality is must remain inconclusive at the moment, but
I strongly suspect that it is bound up with the absorption of excess
refined sugar, found in modern diet, causing renal acidosis and thus
inhibiting tubular reabsorption of calcium. At the moment we are
investigating the effects of various sugars on calcium absorption and
the initial results are encouraging.
Finally, I think it is reasonable to conclude from the results
detailed in this Chapter that stone recurrence may be diminished by
51.
therapy directed at reducing the intestinal absorption of calcium and




THE ROLE OP CELLULOSE PHOSPHATE IN THE TREATMENT OF UROLITHIASIS
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3.1 Introduction
The results detailed in Chapter 2 provide further support for
using methods of treatment which reduces the intestinal absorption of
calcium and therefore its urinary excretion in the management of
recurrent urolithiasis.
Dietary measures have already been used towards this end and
Nordin (1972) considers that a diet low in calcium and oxalates is the
simplest and most effective approach to the treatment of renal stone.
Sodium phytate has been shown to form a relatively insoluble complex
with calcium in the gut and the effect of this has been to lower
urinary calcium in patients with idiopathic hypercalcuirea (Henneman,
et al. 1958). Further investigations of the effects of sodium phytate,
however, has shown an increase in urinary phosphates concomitant with
the decrease in calcium absorption (Parfitt et al. 1964). Oral
administration of sodium phosphate also reduces intestinal calcium
absorption and urinary excretion, but urinary orthophosphate increases
at the same time. Therapeutic use ox both sodium phytate and sodium
phosphate is therefore accompanied by the possibility of an increase
in calcium phosphate precipitation on account of the increase in its
activity/product ratio (Pak et al. 1970).
The thiazides as a group reduce urinary calcium excretion and
increase renal excretion of phosphate as pyrophosphate with a
concomitant increase in the urinary sodium and potassium. Calcium
balance studies carried out at the time of thiazide treatment suggest
that calcium is retained during such treatment. (Lamberg and Kuhlback,
1959; Lichwitz et al. 1961; Higgins et al. 1964; Yendt et al. 1966;
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Harrison and Rose, 1968).
Sodium cellulose phosphate, the sodium salt of the phosphoric
ester of cellulose (Whatman Biochemicals Ltd) is an ion exchange
cellulose with special affinity for divalent cations because of the
steric configuration of the phosphate radicals attached to the cellulose
molecule. In the stomach it exchanges sodium for calcium, which is
eliminated in the faeces, so preventing the absorption of dietary
calcium and it similarly binds secreted calcium preventing its
reabsorption. The diminution in calcium absorption is accompanied by
a reduction in the renal excretion of calcium and a slight increase in
urinary phosphorus but the urine saturation with brushite (CaHPO^ 2^0),
a probable nidus for calcium stone, is reduced Pak (1973).
This Chapter describes some observations on the effect of sodium
cellulose phosphate on intestinal calcium excretion in patients with
urolithiasis, along with the results of a limited clinical application
of the substance.
3.2 Materials and Methods
The effect of cellulose phosphate was evaluted in a series of
patients from the Department of Urology in this hospital in conjunction
with Surgeon Captain N. J. Blacklock, consultant Urologist and head of
the Department. All the patients had full general and metabolic
investigation including excretion urography. Cases of overt hyper¬
parathyroidism were excluded.
Intestinal calcium absorption was measured by the technique of
external radioisotope counting described in Chapter 1. The normal range
of absorption established by this method being 25 to 35 psr cent of the
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calcium meal.
Urinary calcium excretion was assessed with 24 hour specimens of
urine by atomic absorption spectroscopy using the Unicam SP.90.
Hyj.ieroa.ioiuria w&sa taken ae the exonation of mate than 300 sag af
calcium per day in the male and more than 250 mg of calcium per day in
the female. (Hodgkinson and Pyrah, 1958).
The serum calcium, inorganic phosphate, protein and alkaline
phosphatase were estimated on at least four separate occasions at the
outset and at each attendance for follow-up examination with the
patient in the fasting state. Serum calcium was measured by auto-
analyser using Technicon Method N3b and the upper limit of normal for
this laboratory was taken as 10.5 mgms per 100 ml. Serum iron, copper
and magnesium were measured in each patient initially, and subsequently
at each follow-up examination. Serum iron was measured by Richterich's
method and copper and magnesium by atomic absorption spectroscopy
(Unicam SP.90).
3.3 Results
Initially the effect of sodium cellulose phosphate on ^Ca uptake
was evaluted for varying conditions of dosage and administration. In
all the tests described, with the exception of the investigation into
the effect of time of administration of cellulose phosphate on calcium
absorption, the cellulose phosphate was taken in water within 5 minutes
of the oral dose of ^GaGl^ given on the second day of the absorption
measurement protocol.
5g dose
In 10 patients who were given 5g of the substance there was a
marked reduction in Ca absorption (Table 3.l).
TABLE 3.1
Effect of cellulose phosphate on ^Ca absorption in cases
known to absorb calcium excessively from the intestine
^Ca Absorption












Effect of varying dose
Two patients were given lg cellulose phosphate, a further two
patients 2g and a fifth patient 3g and then 5g at the appropriate time
in an uptake test. The effect appeared to be closely related to the
dose (Figure 3«l).
5g reduced the intestinal calcium absorption by as much as 85 per
cent and even a lg dose resulted in a 50 per cent reduction. The 5g
sachet provided as the standard dose therefore has a wide margin for
effective action in this respect. Such a dose, however, is probably
essential when it is considered that the substance will ordinarily be
dispersed throughout a semi-solid food bolus.
Urinary calcium excretion was measured concurrently with the
absorption test and administration of the various doses of cellulose
phosphate.
The results show an inverse relationship between both fractional
calcium absorption and urinary calcium excretion and increasing doses of
sodium cellulose phosphate (Figure 3.2).
Effect of varying time of taking the cellulose phosphate
The influence on calcium absorption of taking a 5g dose of sodium
cellulose phosphate at variable intervals of time from a calcium meal
was evaluated (Figure 3.3).
Maximum effect was achieved if the substance was taken with a meal
or within one hour thereafter. There was a marked reduction in effect
if the substance was taken more than one hour afterwards. Bearing in
mind that the calcium meal was in liquid form in these tests, it is
likely that the dose relationship of sodium cellulose phosphate to a
1G 1G 2G 2G 3G 5G
CELLULOSE PHOS. DOSE /GMS.
FIGURE 3.1 Effect of variable dosage of sodium cellulose phosphal
on intestinal calcium absorption
FIGURE 3.2 Comparison of the influence of varying dosage of sodium




FIGURE 3.3 The influence of time between a calcium containing meal
and dose of sodium cellulose phosphate on the reduction
of intestinal calcium absorption
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normal meal is even more critical.
Effect of 5g dose on urinary calcium excretion
The effect of sodium cellulose phosphate on urinary calcium
excretion was assessed in a number of patients with hypercalciuria of
varying degree (Figure 3.4)•
In all these patients, 5g of 'the substance, taken 3 times daily at
meal-times, effectively reduced urinary calcium excretion to within
normal limits.
Effect of cellulose phosphate on other divalent cations
Serum levels of calcium and phosphorus were not altered in any of
the patients even when cellulose phosphate had been taken for a period
as long as seven years in a dose of 5g> three times daily. (Figure 3.7)•
Since the action of sodium cellulose phosphate is not selective as
regards the divalent cations it can absorb, there is the theoretical
possibility of trace metal deficiencies in long-term usage, bent et al.
(1964) found a fall in plasma magnesium from 2.0 to 1.4 mEq/h. Pak
(1973) noted a reduction in the serum concentration of magnesium and its
renal excretion in a majority of cases. He found it did not significantly
affect the metabolism of copper or zinc. Pietrek and Kokot (1973) noted
a trend towards reduction in the levels of serum magnesium, iron, copper
and zinc concentrations although this was not statistically significant.
In the series of patients investigated in this report who were
treated with cellulose phosphate, without magnesium supplement, for
various periods of time there appears to have been little significant
effect on plasma magnesium (Figure 3«5)« Qne case treated for more than
4 years has a serum magnesium of 2.2 mg/lOO ml. another treated for a
FIGURE 3,4 Effect of sodium cellulose
phosphate on urinary calcium








FIGURE 3.5 Variation in serum levels of iron
copper and magnesium with long
term sodium cellulose phosphate
treatment.
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similar period however, has a level of 1.4 mg/lOO ml.
Serum copper and iron appears to have been largely uninfluenced.
In two cases who have been taking cellulose phosphate for more than three
years the serum iron at present is 50 and 60 mg/lOO ml. respectively,
the lower level of normal. (Figure 3.5)*
Clinical evaluation of Sodium Cellulose Phosphate in recurrent Calcium
Urolithiasis
All cases treated with sodium cellulose phosphate had a history
of recurrent urolithiasis and were hypercalciuric. The duration of
treatment up to the present time is variable, ranging from some months
to several years.
Sodium cellulose phosphate in our experience is easy to take and
is quite palatable. Intestinal upset and diarrhoea which had been noted
by others (Rose and Harrison, 1972) have not been encountered.
The urinary calcium excretion was measured in a number of patients
at various intervals of time from the time of commencing treatment.
(Figure 3.6).
In two patients, hypercalciuria persisted but a subsequent
satisfactory reduction in calcium excretion followed supplementing the
treatment with a low calcium diet. One of these cases had a ^Ca uptake
of 70 per cent. The majority show a satisfactory reduction of calcium
excretion to within normal rates.
Pietrek and Kokot (1973) have found the urinary calcium to be
consistently maintained at reduced levels when using cellulose phosphate
but others (Harrison and Rose, 1972) have had the impression that the
initial reduction is not maintained. This is probably a measure of the
Urinary calcium excretion at interval follow-up
(70%) = 47Ca. absorption
FIGURE 3.6 Urinary calcium excretion at various intervals from
commencement of treatment with sodium cellulose phosphate
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tendency to default v/ith treatment after a time rather than an indication
of the development of resistance in some form to its effect.
Both Pak (1973) and Pietrek and Kokot (1973) already have some
avidenao of a roduood frsquanoy of stona inoidanoe with this treatment.
The effect of the preparation in a number of patients in the series
reported here, who have been treated for several years, is shown
graphically. (Figure 3-7).
Only 2 new stones have been formed in the 9 cases depicted.
In both of these there was an additional aggravating factor of service
in a tropical climate at the time of the recurrence and both were
engaged on watchkeeping duties at sea when there was difficulty in
relating cellulose phosphate dosage to irregular meals. Case P.H. has
shown the most significant response. This patient had consistently
formed several stones annually from 1956 until the time of starting
treatment v/ith sodium cellulose phosphate in 1969. The majority of stones
passed had been calcium oxalate but several were "mixed". Since treatment
was started there has been no further instance of urinary colic or
passage of a stone, and his urinary tract is demonstrably clear of opaque
calculi at the present time. No other therapy or dietary means of control
has been adopted by this patient in the meantime.
3.4 Discussion
In Chapter 2 the significance of excessive intestinal calcium
absorption and hypercalciuria in a high proportion of recurrent stone
formers v/as discussed. The results provided further support for a
rationale of treatment directed at reducing intestinal calcium absorption
and through this, the renal filtered load of calcium and urinary calcium
excretion.
Whilst on sorvico || Stono psnod ■ Stono nmond fl540"*
in tho tropics. i spontanoosly. I «t operation. U in «<"•
FIGURE 3.7 Graphic representation of stone incidents in 9 cases "both
before and after the commencement of sodium cellulose
phosphate treatment
This may be affected, in whole or in part by dietary control and
Nordin (1972) has described a low calcium, 1ow oxalate diet as the
simplest and most effective regime. Dietary control, however, whilst
being an ideal form of management in a metabolic unit poses formidable
problems to the patient in the home and working conditions, especially
when circumstances necessitate meals away from home as when travelling,
and when feeding is institutional. In these circumstances there is a
need for an effective agent to reduce the absorption of ingested calcium.
Sodium cellulose phosphate is demonstrably effective in this respect and
so far has proved innocuous. It is considered that there is a case for
its use, suitably monitored, in cases of recurrent urolithiasis who have
been shown to absorb calcium excessively from' the intestine and to be
hypercalciuric.
We have investigated other agents effective in removing calcium
from the diet in an insoluble bound form and thus eliminating it in the
faeces. As mentioned in Chapter 2 we are currently investigating the
effect of refined sugars on calcium absorption and the implications are
that these sugars are involved in the evident increase in urolithiasis
and hyperabsorption of calcium in the industrial highly developed
countries of the world. It may well be that the ability of sodium phytate
to bind calcium and prevent its absorption (Henneman et al. 1958), and
the low consumption of refined carbohydrates are major factors in the
evident low morbidity due to renal stone in populations of less
developed and agricultural countries with high intake of wholemeal products
such as bran or oatmeal, in their diet eg. the Highlanders of Scotland.
While it has been shown by Parfitt et al. (1964) that sodium phytate
increases the amount of urinary phosphates, thus apparently negating the
benefits of reduced calcium absorption, the overall beneficial effect of
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wholemeal products in combating the suspected and evident defects in
absorption and diet, due to excess of refined sugar, is becoming more
obvious. This is not confined solely to urolithiasis but is increasingly
recognised in the aetiology and treatment of a multiplicity of gastro¬
intestinal disorders today.
Whatever the outcome of this work in progress, it is evident from
the results detailed in this Chapter that sodium cellulose phosphate is




CALCIUM ABSORPTION IN HYPERPARATHYROIDISM
4.1 Introduction
In any aeries of patients investigated for renal stone one of the
main features is hypercalciuria (Flocks, 1939; Hodgkinson and Pyrah,
1958). The phenomenon of hypercalciuria with an associated tendency to
hypophosphateamia and a normal serum calcium was described as the syndrome
of idiopathic hypercalciuria by Albright et al. (1953) and Henneman et
al. (l958)> Peacock et al. (1967) confirmed these observations and
suggested that the intestinal absorption of calcium was increased in most
patients. In Chapter 2 in a detailed investigation of 125 cases of
urolithiasis it is shown that 82 per cent of patients were absorbing
calcium excessively from the intestine thus supporting Peacock's findings.
When this is considered along with the results of cellulose phosphate
therapy shown in Chapter 3 it would tend to indicate that a primary
abnormality in intestinal absorption, probably related to the absorption
of refine sugars, was responsible for the increased calcium absorption.
Patients with idiopathic hypercalciuria may show some of the
biochemical abnormalities found in those with primary hyperparathyroidism
presenting with renal stone. The urinary calcium is commonly raised in
primary hyperparathyroidism and hypophosphateamia while reduced renal
tubular reabsorption of phosphate is found in both conditions (McGeown,
1957). Usually in primary hyperparathyroidism the serum calcium is
increased but this is not a consistent finding as has been shown by
Yendt and Gagne (1968) and Wills et al. (1969).
Since abnormalities of calcium and phosphorus metabolism are common
to both patients with idiopathic hypercalciuria and those with primary
hyperparathyroidism presenting with renal stone it may be agreed that
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the pathological basis for such abnormalities is the same in both
conditions. It was suggested by Albright et al. (1953) that the changes
found in phosphorus metabolism in patients with idiopathic hypercalciuria
were due to parathyroid overactivity. They stated that this was secondary
to hypercalcaemia caused by excessive loss of calcium in the urine due
to a primary abnormality in the renal tubular handling of calcium. Other
workers however, have shown that in idiopathic hypercalciuria the serum
calcium concentration tends toward the upper limit of normal (Peacock et
al. 1968) and that the renal tubular reabsorption of calcium is generally
normal in these patients (Peacock and Nordin, 1968).
Adams et al. (1970) were able to demonstrate hypercalcaemia in 8
out of 19 patients with idiopathic hypercalciuria following provacative
tests of parathyroid activity based on phosphate deprivation and the
administration of chlorathiazide. Subsequent exploration of the neck on
five out of these eight patients with hypercalcaemia showed four of them
to have parathyroid adenomas and the fifth patient had 'normal glands'
but responded satisfactorily to subtotal parathyroidectomy.
That increased calcium absorption in patients with idiopathic
hypercalciuria presenting with renal stone is a primary phenomenon, rather
than secondary to increased losses of calcium in the urine, is amply
demonstrated in Chapter 2 of this work and supported by the findings of
others (Henneman et al. 1958; Harrison, 1959; Peacock et al. 1968).
It has also been shown by Wills et al. (1970) that the parathyroids
play a small but significant role in the gastro-intestinal absorption of
calcium. They found that in six normal subjects and in one patient with
idiopathic hypoparathyroidism there was a small increase in calcium
absorption from the gut during the administration of parathyroid extract.
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In a series of patients with urolithiasis who were investigated in
this Department during the period January 1970 until September 1973 a
certain number were found to be hyperealcaemic and were therefore excluded
from the 125 cases whose detailed investigations are described in Chapter
2 of this work. This Chapter describes some observations made on these
patients and others, referred from the metabolic unit of Southampton
General Hospital with hypercalcaemia, and compares them with a control
group and patients with normocalcaemic recurrent nephrolithiasis.
4.2 Materials and Methods
Fifteen patients v/ere referred to this department for investigation
of hypercalciuria with and without renal stones and in whom primary
hyperparathyroidism was suspected. A comparison was made between these
patients, a group of 47 patients with recurrent urolithiasis whose serum
calcium measurements v/ere within normal range, and 20 control subjects
who had no apparent abnormalities of calcium metabolism.
411 the patients from these three groups had their serum calcium
and inorganic phosphate measured on at least four separate occasions.
Their 24 hour urinary calcium v/as measured by atomic absorption
spectrophotometry (Unicam SP.90). Urinary cyclic AMP (adenosine 3':5' -
monophosphoric acid) was estimated using the* standard Amersham radio¬
immunoassay kit based on the protein binding assay of Gilman (1970) and
the results expressed asyumol/g creatinine. Serum parathyroid hormone
v/as estimated in collaboration with Dr Buckle of the Metabolic Unit,
Southampton General Hospital using a modification of the radio-immunoassay
technique detailed by Arnaud et al. (1971)•
Following these investigations 12 of the 15 patients had neck
explorations and subsequent sub-total parathyroidectomy for parathyroid
adenoma in ten cases and parathyroid hyperplasia in the remaining two.
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Intestinal calcium absorption was measured in all patients and
controls by the arm counting method detailed in Chapter 1. The 12 patients
who had sub-total parathyroidectomy performed had their calcium absorption
measured subsequent to the operation in order to compare the pre and post
operative calcium uptake.
4.3 Results
Serum Calcium and Phosphorus
Measurements of serum calcium and phosphorus in all 20 control
subjects showed a mean serum calcium of 9.82 - 0.51 mg/lOO ml. and a
mean serum phosphorus of 3.72 - O.64 mg/lOO ml. (Table 4«l)« T*1 n0
subject was the serum calcium greater than 10.5 mg/lOO ml. or the serum
phosphorus less than 2.6 mg/lOO ml. the upper limit for serum calcium
and the lower limit for serum phosphorus for this laboratory.
In the 15 patients with suspected primary hyperparathyroidism serum
calcium was greater than 10.5 mg/lOO ml. in 12 cases and within the
normal range in the remaining three. The mean value was significantly
raised at 11.62 ^ 0.42 mg/lOO ml. The mean serum phosphorus for this
group was 2.74 - 0.42 mg/lOO ml. significantly lower than that for the
control group. In the 47 patients with recurrent urolithiasis both mean
serum calcium and serum phosphorus were within normal limits, and in no
case was the serum calcium above 10.5 mg/lOO ml. or the serum phosphorus
below 2.6 mg/lOO ml.
24 hour urinary calcium (Table 4*l)
24 hour urinary calcium measurements on control subjects showed a
mean excretion of 164 - 44 mg/24 hours. In no subject was the urinary
calcium greater than 250 mg/24 hours. In the primary hyperparathyroid
group the mean calcium excretion was 458 - 54 mg/24 hours and in all
cases was significantly raised above the normal upper limit of 300 mg/24
TABLE4.1
Ineachgroupofpatientsthresultsapres
themean-S.D.oft anvaluesfr mindi id lpatients
NumberMeanserums rueanrinary ofcalciumphosphoruscalcium Patientsmg/lOOl./l l/24hrs.
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hours for this laboratory.
The patients with recurrent urolithiasis showed a mean urinary
calcium of 34& - 104 mg/24 hours again significantly raised above
tthrwal in 42 cases ana within nn#snal liaise in the remaining 5.
Urinary cyclic AM? (Table 4«l)
In the control group urinary cyclic AMP was less than 5ytunol/g.
creatinine with a mean value of 4*12 - 0.62yumol/g. creatinine. Among
patients with primary hyperparathyroidism the mean value for urinary
cyclic AMP was 8.34 - 2.58ynmol/g. creatinine, significantly higher
than in the control group. The mean value for the patients with
recurrent urolithiasis was 3.64 - 0,7yumol/g. creatinine slightly less
than on the control group.
Serum parathormone (Table 4«l)
Among the control subjects radioimmuno assay of serum parathormone
gave a mean value of O.4O - 0.28yug eq/ml. Patients with hyperpara¬
thyroidism showed a mean value of 1.74 - 0.31yug eq/ml. In 12 out of
the 15 patients serum parathormone was greater than 1yug eq/ml which is
the accepted upper limit of normal for this technique. The patients
with recurrent urolithiasis showed a mean'of 0.31 - 0.23yu eq/ml and
none of these patients had a serum level above 0.34yug eq/ml.
Intestinal ^Ca absorption (Table 4*l)
Mean calcium absorption expressed as percentage absorption of a
measured oral dose of ^^GaCl^ among control subjects was' 30-6 per cent
of the oral dose. Patients with recurrent urolithiasis had a mean
absorption of 56 i 16 per cent showing a significant increase in
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intestinal calcium uptake. The hyperparathyroid group with a mean calcium
absorption of 64 - 19 pez cent of the oral dose, were also significant
calcium hyperabsorbers.
With these results favouring a biochemical diagnosis of hyperpara¬
thyroidism in at least 12 of the suspected group of 15, it was decided
to surgically explore the 12 most likely cases. Of these 12 patients
10 proved to have parathyroid adenomas and in the remaining two parathyroid
hyperplasia was demonstrated. Following sub total parathyroidectomy a
satisfactory reduction in hypercalciuria and intestinal calcium
absorption was immediately apparent. Measurements of ^Ca absorption
pre and post operatively are detailed in Table 4.2.
'
1 J/* •
Further examination of the results in patients with hyperparathyroidism
shows good correlation between urinary cyclic AMP and serum parathormone
(correlation coefficient = 0.875) (Figure 4«l)» Comparisons of serum
calcium with urinary cyclic AMP (Figure 4.2) and serum parathormone
(Figure 4«3) show most measurements to lie outside the normal range but
without an apparent relationship.
There was no obvious correlation between intestinal calcium
absorption and urinary cyclic AMP or serum parathormone.
4.4 Piscussion
Hypercalciuria is frequently the most consistent feature of
hyperparathyroidism and is the hallmark of idiopathic hypercalciuria.
In this work another common factor became apparent in that intestinal
hyperabsorption of calcium in 82 per cent of patients with urolithiasis
and in all the patients referred for parathyroid investigation became
obvious. The hyperabsorption of hyperparathyroidism is recognized as
being secondary to excessive calcium loss in the urine and the expression
TABLE 4.2
Results of calcium absorption measured by external radioisotope
counting before and after sub-total parathyroidectomy
^Ca Absorption ^Ca absorption
Subject before operation after operation
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'resorptive hypercalciuria1 has "been used to describe this because of
the frequent association with excessive skeletal resorption (Nordin,
Peacock and Wilkinson, 1972). The hypercalciuria encountered in 77
cent of the recurrent urolithiasis group discussed in Chapter 2 is due
to a primary increase in calcium absorption from the intestine and could
correspondingly be called an 'absorptive hypercalciuria'. This
observation has been supported by other workers (Norden et al. 1972;
Pak et al. 1972 and Pak, 1973). The importance of a third possible
cause of hypercalciuria due to excessive carbohydrate intake is
currently being investigated by us, the theory being that excess
absorption of refined sugars in modern diet causes a renal tubular
acidosis thus inhibiting tubular reabsorption of calcium. Other workers
(Pak, 1973; Coe et al. 1973) have commented on this 'renal leak'
hypercalciuria and have associated it with secondary hyperparathyroidism.
In practical terms the differentiation between primary hyper-
absorption of calcium and secondary hyperabsorption due to parathyroid
induced hypercalciuria is imperative since optimal treatment depends
on the exact aetiology. In this Chapter an attempt to indicate the
differences between the two types of hyperabsorption has been made,
resulting in the successful diagnosis of 12 cases of hyperparathyroidism,
confirmed at operation. In contrast the patients with recurrent
urolithiasis were appropriately treated with sodium cellulose phosphate,
as detailed in Chapter 3, to directly inhibit intestinal absorption of
calcium.
In comparing the patients with hyperparathyroidism with those
exhibiting recurrent urolithiasis both groups showed excessive intestinal
calcium absorption and 24 hour urinary excretion as compared to the
control group. Both the mean calcium absorption and mean urinary calcium
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excretion, however, were higher in the primary, hyperparathyroid group
when compared with patients with recurrent urolithiasis. These groups
differed in that the mean serum calcium, the mean urinary cyclic AMP and
the mean serum parathormone were significantly above the recognised
upper limits of normal in those patients with hyperparathyroidism and
in that there was a significant relationship between urinary cyclic AMP
and serum parathormone in the hyperparathyroid group. The patients with
recurrent urolithiasis or 'absorptive hypercalciuria', on the other hand,
had mean serum calcium and parathormone and the mean urinary cyclic AMP
within normal limits. A further difference was evident in measurements
of the serum phosphorus concentration in that the hyperparathyroid group
showed levels significantly lower than those found in both recurrent
urolithiasis and control groups.
It appears from this that patients who, in addition to the common
features of hypercalciuria and excessive intestinal calcium absorption
found in the 'absorptive' and 'resorptive' types of idiopathic hyper¬
calciuria, exhibit a raised serum calcium and serum parathormone, a
raised urinary cyclic AMP and a lowered serum phosphorus must be
regarded as suffering from hyperparathyroidism and elective surgery
seriously considered. Those patients who exhibit excessive intestinal
absorption and urinary excretion of calcium only are 'absorptive'
hypercalciurics and should be treated by reducing their calcium
absorption with a low calcium diet or by administering calcium inhibitors
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MEASUREMENT OF ORAL CALCIUM ABSORPTION FROM THE
GUT BY EXTERNAL ISOTOPE COUNTING
By Murdoch A. Macleod
ABSTRACT
Among the factors which regulate normal gastro-intestinal calcium absorption, current thought
recognises calcium intake, vitamin D and parathyroid hormone as playing an important part.
It is well documented that gastro-intestinal calcium absorption is reduced in states of mal¬
absorption, hypoparathyroidism and in patients with chronic renal failure, and raised in states of
hyperparathyroidism, urolithiasis and idiopathic hypercalcuria.
Difficulties inherent in classic calcium-balance techniques have prompted a search for more
practical and reliable methods of measuring the degree of impairment of calcium absorption.
This paper describes a study of intestinal calcium absorption in 10 normal subjects and four
patients, with various disorders of calcium metabolism, using an external radio-isotope counting
technique.
Introduction
During the past decade, interest in calcium metabolism has greatly expanded and with
current methods of measuiement of calcium absorption, both time consuming and requiting
hospitalisation with strict metabolic regimen, a simple more direct method would be of
great advantage. Measurement of serum calcium alone will only give the equilibrium figure
between calcium input into the bloodstream (net absoiption and bone resorption) and calcium
output (bone mineralisation and renal excretion) at the time of measurement and will not
necessarily reflect quite large changes in any one of these parameters. For example, the concept
that there exists a 'steady state' or physio-chemical equilibrium between blood and bone
calcium, the level of which is determined by parathyroid activity, is not supported by recent
work (Noidin and Peacock, 1969). The technique developed here, based on the work of
Curtis, Fellows and Rich (1967) is simple, does not inconvenience the patient and only requires
a few minutes of time on each of three consecutive days to perform. This method is based on
the assumption that the distribution in the body of an absorbed part of an oral dose of calcium
is identical to that of an entire intravenous dose, thus the fraction of a known IV dose
measured in the forearm in this case, will be the same as that of an absorbed dose. Knowing
the exact amount of the isotope given orally, it is then easy to calculate the exact amount
absorbed from the gut.
Materials and Method
Initial studies were carried out on eight volunteer subjects from the medical staff of the
Institute of Naval Medicine who had no evident disorders of calcium metabolism or intestinal
function. The isotope used was Ca47 a 1.31 Mev y emitter with a 4.53 day half-life. The forearm
being relatively small and freely mobile is especially suited to external counting and was
used in all measurements. Preliminary studies showed that it took approximately 24 hours for
a small IV dose of Ca47 Cl2 to reach equilibrium in the tissues, bone and blood. Decay from
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Fig 1. Ca*7 decay in the forearm following IV injection.
that time onwards being exponential, 24 hours was selected as a suitable time at which to
measure arm activity.
The apparatus used to carry out arm activity measurements comprised a large volume lead
chamber incorporating two Nal (Tl) 4 inch scintillation crystals in apposition with a curved
plastic arm rest and hand grip between them, to ensure constant geometry when counting
the forearm on subsequent days. Counts were recorded on an Ortec timer/sealer.
On the first day, preliminary control arm background counts were made on all subjects.
Each was then given 1 pCi Ca47 Cl2 in 1 ml saline IV. On day two, ie, 24 hours after the
injection, the background count rate was measured with the subject in position beside the
chamber, but with his arm outside. Following this count, the forearm was inserted into the
1 chamber and counted for 100 seconds. On completion, each subject was given to drink
10 pCi Ca47 Cl2, in 100 mg calcium gluconate solution made up to 100 ml with water. Subjects
fasted at least 12 hours before and two hours after this oral dose.
On the third day, 26 hours after the oral dose on the second day, ie, two hours for complete
absorption of the oral dose from the intestine in the fasting patient plus the 24 hours required
to achieve equilibrium, background count rate was again established and arm count rate
subsequently measured. A similar final measurement was made on day four, 50 hours after the
oral dose.
90 Journal of the Royal Naval Medical Service Volume 57 Summer 1971
Results
Arm count rate corrected for arm background and decay is expressed as arm activity (A),
measured at 24 hours after injection (AJ, 26 hours after the oral dose (A2), and 50 hours after
IV
the oral dose (A3). The ratio, intravenous dose to oral dose ■— is constant and the biological
A3
decay for a 24 hour period can be expressed as the fraction — . From these measurements, it
can be shown algebraically that the absorbed fraction (F) of the oral dose is,
The results obtained from the 10 normal subjects gave parameters of amounts of calcium
absorbed from the gut of 25 per cent — 32 per cent (± 2.5 per cent) with a mean of 28.5 per
cent (see Table 1).
Table 1
ai A2 a3 Absorbed %
Subject cc/100 sec cc/100 sec cc/100 sec iv/10 Fraction 'F' Absorption
R.M. 3,490 16,500 14,540 0.08 0.32 32
I.L. 3,200 14,330 11,500 0.08 0.30 30
H.G. 2,270 9,600 8,016 0.08 0.28 28
D.M. 2,680 9,840 7,600 0.1 0.30 30
R.L. 3,250 12,100 9,680 0.08 0.26 26
P.O. 2,980 12,500 10,030 0.08 0.28 28
D.S. 3,950 16,800 13,500 0.08 0.29 29
P.B. 3,500 13,610 10,900 0.08 0.25 25
I.L. 2,800 10.400 8,500 0.1 0.29 29
P.G. 3,840 15,200 13,500 0.1 0.31 31
This compares favourably with a mean calcium absorption of 26.5 per cent in a similar
study carried out by Curtis et al (1967) on 12 normal subjects who had conventional stool
calcium estimations carried out at the same time giving a calculated mean calcium absorption
of 25.1 per cent.
Approximately 50 measurements of calcium absorption have now been carried out on
hypo and hyper-calcuric patients, with and without urolithiasis and it is hoped to present
the findings in these cases at a later date. Table II shows results obtained from a sample of
these patients.
Table II





D.K. Urolithiasis 1,650 15,800 14,200 0.70 70
R.B. Idiopathic Hypercalcuria 1,410 8,700 8,500 0.52 52
J.L. Hypoparathyroid 2,250 7,200 7,100 0.18 18
P.H. Iatrogenic Hypercalcuria 1,260 8,500 7,300 0.59 59
I
Discussion
The method of measuring calcium absorption from the gut described here fulfils the
proposed criteria, being simple and quick to perform with minimum inconvenience to the
patient. It also avoids the inaccuracy introduced in the stool collection method by the excretion
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of previously absorbed calcium by the lower colon. Sources of error inherent in the technique
lie in the prior assumptions and the experimental conditions obtaining. Among these are the
assumption that the oral dose is maximally absorbed within two hours of administration but
there is now ample evidence that, in a fasting patient, under the conditions of the test, ab¬
sorption is rapid and essentially complete at two hours (De Grazia, Ivanovitch, Fellows and
Rich, 1965; Avioli, McDonald, Singer and Henneman, 1965). There is a considerable amount
of isotope remaining in the gut at the time of counting, 26 and 50 hours after the oral dose,
but, with correct positioning of the patient in relation to the chamber, ie, close against the
* lead wall so that no part of the body is seen through the port by the detectors, and careful
background counting, the effect of this surplus radioactivity in the gut can be minimised.
The principal advantage which recommends this external counting method is its simplicity.
Uncertainty regarding complete stool and urine collection and accuracy of the meticulous
laboratory techniques is avoided and the patient is not embarrassed or inconvenienced. The
method deserves consideration as a routine laboratory investigation.
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Calcium-47 Absorption in Urolithiasis
N. J. BLACKLOCK and M. A. MACLEOD
Department of Urology and Department ofNuclear Medicine, Royal Naval Hospital, Haslar, Gosport, Hants
An association between high urinary calcium and calcium urolithiasis was described by Flocks
in 1939 but subsequent work has fallen short of establishing the exact relationship between these
2 phenomena. In a group of patients forming calcium-containing renal stones, Melick and Henne-
man (1958) found that 32% had hypercalciuria. Similar findings have been made by others.
Whilst an excessive urinary calcium is present in other specific diseases, hypercalciuria as a
phenomenon occurring in the absence of any of these was described by Albright et al. (1953).
This syndrome of idiopathic hypercalciuria was defined as the occurrence of a high urinary calcium
in association with normal serum calcium, a tendency to hypophosphataemia and renal stone
formation and it has since been recognised by others.
Caniggia, Gennari and Cesari (1965) suggested that the hypercalciuria was primarily absorptive
in origin. Peacock, Flodgkinson and Nordin (1967) showed the importance of dietary calcium
in demonstrating hypercalciuria, suggesting that the hypercalciuria in stone formers was probably
due to excessive absorption of calcium. An implication of this was that idiopathic stone formers
were largely drawn from that segment of the population in which absorption and therefore
urinary excretion of calcium was above average.
This paper is concerned with the study of a group of stone formers and recurrent stone formers
in the Royal Navy in whom intestinal calcium absorption has been measured by arm counting
using calcium-47 (47Ca).
In the past, techniques for assessing calcium absorption have required the patient to be in
hospital and on a strict metabolic regime and have also required accuracy in the timing and
collection of urine, faecal and blood samples. With the availability of 47Ca, a gamma-emitting
radio-nuclide with a half-life of 4-53 days, a relatively simple and accurate method of measuring
calcium absorption has become available using external scintillation counting (Curtis, Fellows
and Rich, 1967; Wills et al., 1970; Macleod, 1971).
Methods
All the cases of urolithiasis studied were registered in the Royal Naval Renal Stone Survey, which
is supported by grant from the Medical Research Council, and all had a full general and metabolic
investigation and excretion urography performed.
The serum calcium, inorganic phosphate, protein and alkaline phosphatase were estimated
on at least 4 separate occasions with the patient in the fasting state. Serum calcium was measured
by auto-analyser using Technicon Method N3b and the upper limit of normal for this laboratory
was taken as 10-5 mg/100 ml.
Urinary calcium excretion was measured first of all with the patient on a diet containing calcium
supplements since it has been established that hypercalciuria is only detectable at moderately
high calcium intakes (Knapp, 1947; Peacock, Hodgkinson and Nordin, 1967). Thereafter a low
calcium diet (150 mg calcium per day) was given and, after a period of 3 days, further measurements
of calcium excretion were made to establish the response to this. Urinary calcium was estimated
by atomic absorption spectroscopy using the Unicam SP 90.
Gastro-intestinal absorption of radioactive calcium was measured by an arm-counting technique
following separate intravenous and oral doses of 47Ca chloride (Macleod, 1971). This method is
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based on the assumption that the distribution in the body of the absorbed part of an oral dose of
calcium is identical to that of an entire intravenous dose; thus the fraction of a known intravenous
dose, measured in the forearm in this case, will be the same as that of the absorbed dose. Since it
has been reported that restriction of calcium intake, as in a low calcium diet, will increase the
avidity of the absorptive processes for calcium (Malm, 1958; Heaney and Skillman, 1964; Lloyd,
1967) both a control group and the patients prior to January 1972 were on a normal diet except
for a fast of 12 hours before receiving the oral dose of 47Ca on the 2nd day of the test. For various
Table I
47Ca Absorption in Controls
Percentage Calcium Absorption
Subject March 1970 January 1971 July 1972
R. M. 32
I. L. 30 29 36
H. G. 28
D. M. 30 • ••
R. L. 26 30
P. C. 28
R. C. 26
D. S. 29 36
P. B. 25 27 26











reasons during 1972, 49 of 83 patients so tested had started a low calcium diet of 150 mg of calcium
per day at the time of the investigation. Of these, the great majority had calcium absorption
measured within a day or two of starting the low calcium diet and in no case was the measurement
made with the patient more than 5 days on this diet. Comparing the 2 groups, the results showed
no statistical difference; 63% of patients on the low calcium diet and 60% of the patients on a
normal diet were absorbing calcium excessively. This suggests that a low calcium diet for a short
period of time does not influence the process of absorption from the gut. This finding agrees with
the observation of Wills et al. (1970).
Since the publication of the paper describing this technique (Macleod, 1971) the original 10
control subjects have been augmented by an additional 10 and measurements have been repeated
on the previous controls over a period of 3 years. Results in these showed that the amount of the
oral calcium dose absorbed from the intestine was between 25% and 36% with a mean of 30%
(see Table I).
Results
125 cases of urolithiasis were studied. Only 2 of this number were female.
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Of the 125 patients, 23 (18%) absorbed calcium within the normal range; 102 (82%) absorbed
it excessively. The extent of this hyperabsorption of calcium was variable and is shown graphically
in Figure 1. Estimations were repeated in a number of these patients over an 18-month period
Calcium absorption (%)
Fig. 1. Variable intestinal hyperabsorption of 47Ca in 125 cases of urolithiasis.
Table II











E. J. H. 16.11.70 64 13.9.71 51
P. J. D. 14.12.70 76 19.6.72 52
B. L. P. 10. 5.71 77 19.7.71 71
H. J. T. 7. 9.70 44 19.7.71 41
J. F. 20. 9.71 76 10.7.72 55
and these showed that the tendency to absorb calcium excessively remained although there was
some variation of the extent of this (Table II).
A comparison of calcium absorption with 24-hour urinary calcium excretion in the 125 patients
showed that all but 3 who were hypercalciuric were also absorbing calcium excessively from the
intestine (Fig. 2). This confirms observations by others (Flocks, 1939; Zisman, Pak and Bartter,
1967; Wills et al. 1970).
380 BRITISH JOURNAL OF UROLOGY
Two subgroups were formed from the series for comparison. The first was of patients who had
formed only a single stone at the time of investigation. The second group comprised those who
had formed 2 or more stones in clearly separated instances and were therefore recurrent stone
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Fig. 2. Comparison of 47Ca absorption with 24-hour urinary calcium excretion in 125 cases of urolithiasis.
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42 (89%) 36 (77%)
Fig. 3. Comparative incidence of increased 47Ca absorption and hyper¬
calcemia in solitary and recurrent stone cases.
incident but it is recognised that with a sufficiently long follow-up period some of these could have
recurrences at a later date. In other respects both groups appeared to be well matched; the mean
age of the single stone formers was 31 years and that of the recurrent stone formers 34. The
difference in mean age was not significant.
Of 78 cases of apparently solitary stone, 59 (76 %) showed excessive intestinal calcium absorp¬
tion and 31 (40 % of the total) were hypercalciuric. Of 47 cases of recurrent urolithiasis, 42 (89 %)
absorbed calcium excessively from the intestine and 36 (77% of the total) excreted calcium
excessively in the urine at the time of investigation (Fig. 3).
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In the single stone formers the mean calcium absorption was 46% (S.D. 13) and the mean
24-hour urinary calcium excretion was 276 mg (S.D. 116). In the recurrent group, mean absorption
Mean 47 Ca Mean urinary
absorption Ca + + excretion
Solitary 46% 276 mg/day
stone (S.D. 13) (S.D. 116)
Recurrent 56% 346 mg/day
stone (S.D. 16) (S.D. 104)
P<0 025
Fig. 4. Comparison of mean 47Ca absorption and urinary calcium excretion
in solitary and recurrent stone cases.
was 56 (S.D. 16) and mean excretion 346 mg (S.D. 104). The comparison between the 2 groups
shows a significant difference (x2 test to one degree of freedom, P < 0-025) even with the probability
of "contamination" of the first group with a number of potential recurrent stone formers (Fig. 4).
Discussion
Hypercalciuria has been found to occur in approximately one-third of cases of calcium-containing
renal stone in a previous review of cases of urolithiasis in the Navy. The incidence in the present
series is 54 % but this is a spuriously high figure since the recurrent stone former will tend to
be referred to this hospital for full investigation more often than the patient with a single, short¬
lived incident. Excessive urinary calcium excretion has been ascribed to excessive intestinal calcium
absorption (Pyrah, 1958; Harrison, 1959; Parfitt et al„ 1964; Peacock et al., 1967). The results
from the 47Ca absorption studies support this concept. They show that a majority of stone
formers, whether they are hypercalciuric or not, absorb calcium excessively from the intestine
and this is more prevalent in cases of recurrent urolithiasis.
There is only partial correlation between excessive intestinal absorption of calcium and the
occurrence of hypercalciuria. All but 3 of the hypercalciurics were found to absorb calcium
excessively but 49 patients who were absorbing calcium in excess from the intestine were excreting
calcium in normal amounts in the urine at the time of test. Since the 47Ca absorption test deals
only with the percentage absorption of a calcium load it is possible that the normal excretion
resulted from a low calcium intake. All patients, however, were on a standard ward diet with
calcium supplement in the form of a pint of milk per day besides that taken with cereal, tea and
coffee. In the circumstances, if there was a simple linear relationship between calcium uptake
and excretion, greater correlation might have been anticipated. However, since hypercalciuria is
assessed on the amount of calcium in a 24-hour collection of urine, diurnal variations of calcium
concentration will not be apparent; thus, hypercalciuria of varying degree may occur on a number
of occasions within a 24-hour period without there being necessarily overall hypercalciuria
(Marshall, 1972). It may therefore be inadequate to define hypercalciuria as the excretion of more
than 300 mg of calcium in 24 hours in the male and 250 mg in the female (Hodgkinson and Pyrah,
1958). Rose (1967) has pointed out that the normal range of urinary calcium varies from one
country to another and may also vary within a country since Watson and Dale (1966) consider
that in London the excretion of up to 400 mg of calcium per day is normal for a man and 300 mg
per day for a woman.
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In this series, however, there appears to be closer correlation between the intestinal calcium
uptake and urinary calcium excretion in the recurrent than in the apparently solitary stone formers.
An implication of the finding of an increased absorption of calcium in a high proportion of
cases of urolithiasis is that greater quantities of calcium are being presented to the excretory
system and the nephron in particular for excretion. With its known toxicity when present in
excess, cellular damage due to high local concentrations of calcium might occur in the cells of
the nephron or its interstitial tissues. This may be an interpretation of the finding by Anderson
(1968) of foci of calcium phosphate precipitation in the kidneys of patients with a history of renal
stone. Similar foci were present in patients who had no history of stone formation but were
significantly more prevalent in the stone-forming group in which they occurred in 64%. Malek
and Boyce (1973) describe calcium deposits in the kidneys of all of 52 cases of idiopathic calcium
oxalate stone. These observations bear comparison with the present finding of excessive intestinal
absorption of calcium in 82 % of this group of stone formers.
In Anderson's series the calcium phosphate was present within the interstitial tissues and the
epithelial cells of the renal tubules, sometimes extending into the lumen; the loop of Henle and
the collecting tubules were most frequently involved. Boyce (1972) in a study of biopsies of human
kidney found Periodic Acid Schiff (PAS) positive material, usually with concentric laminar
structure and containing calcium in significant quantities, within the lumen of the nephron. He
considered that the origin of this material was in the proximal renal tubule and that there was
subsequent migration to the collecting ducts. He attributed the high incidence of medullary
concretions to the coalescing ductal anatomy. Cooke (1972) in a radio-isotope study demonstrated
a marked calcium concentration gradient ranging from maximal in the papilla tip to minimal in
the cortex of the kidney; he also found differences in the calcium content of anatomically com¬
parable regions of the kidney when he compared specimens from a population group with and
another without a tendency to form renal stones.
It is well known that calcium salts tend to be deposited in tissues which are already damaged
or undergoing degeneration. Scarparelli, Tremblay and Pearse (1960), in drawing attention to this,
pointed out that the damaging agent in some cases could be an excess of calcium itself. Cells
which are involved in the metabolism or transport of calcium—as are the cells of the nephron—are
probably protected against its toxic effects within certain limits. An excess of calcium, however,
may overwhelm a protective mechanism and result in tissue damage and subsequent calcium
deposition.
The lesions described by Anderson (1968) and others may therefore be primary and stone
formation in the tubules and calyces a secondary phenomenon due to crystallisation on a calcified
nidus extruded from the epithelium of the tubules. Theymay be a direct consequence of a metabolic
abnormality resulting in the increased intestinal absorption of calcium as found in such a high
proportion of this series of stone formers.
Summary
The intestinal calcium absorption was measured in a group of stone formers using an external
isotope counting technique.
Hyperabsorption was found in 82% and was even more prevalent in the recurrent cases.
Comparison of absorption with urinary calcium excretion showed greater correlation in a
group of recurrent stone formers than in cases of apparently solitary stone formation.
The finding of intestinal hyperabsorption of calcium in a high proportion of stone formers may
be aetiologically significant in the parenchymal calcium deposition found in these cases.
Part of the work of this project was supported by a grant from the Medical Research Council.
Our thanks are due to Mr Stephen Gray of the Department of Biochemistry, Royal Naval Hospital, Haslar, for
laboratory assistance in this project.
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The Effect of Cellulose Phosphate on Intestinal
Absorption and Urinary Excretion of Calcium
Some Experience in its use in the Treatment of Calcium Stone Formation
N. J. BLACKLOCK and M. A. MACLEOD
Department of Urology and Department of Nuclear Medicine, Royal Naval Hospital, Haslar, Gosport, Hants
The findings in a previous paper have provided further support for regimes of treatment which
reduce the intestinal uptake of calcium and therefore its urinary excretion in the management of
recurrent calcium urolithiasis (Blacklock and Macleod, 1974).
Dietary measures have already been used towards this end and Nordin (1972) considers that a
diet low in calcium and low in oxalates is the simplest and most effective approach in the treatment
of this condition. Sodium phytate has been shown to form a relatively insoluble complex with
calcium in the gut and the effect of this has been to lower urinary calcium in patients with idio¬
pathic hypercalciuria (Henneman et al., 1958); there is however an increase in urinary phosphate
excretion at the same time (Parfitt et al., 1964). Oral administration of sodium phosphate similarly
has the effect of reducing intestinal calcium absorption and urinary calcium excretion but the
urinary phosphorus excretion in the form of orthophosphate increases at the same time. Thera¬
peutic use of both sodium phytate and sodium phosphate is therefore accompanied by a possibility
of increased tendency to calcium phosphate precipitation on account of the increase in its activity
product ratio. (Pak et al., 1971). The thiazides as a group reduce urinary calcium excretion and
increase renal excretion of phosphate as pyrophosphate with a concomitant increase in the urinary
sodium and potassium. Calcium balance studies carried out at the time of thiazide treatment
suggest that calcium is retained during such treatment (Lamberg and Kuhlback, 1959; Lichwitz
el al., 1961; Higgins et al., 1964; Yendt, Gagne and Cohamin, 1966; Harrison and Rose, 1968).
Sodium cellulose phosphate, the sodium salt of the phosphoric ester of cellulose (Whatman
Biochemicals Ltd) is an ion exchange cellulose with special affinity for divalent cations because
of the steric configuration of the phosphate radicals attached to the cellulose molecule. In the
stomach it exchanges sodium for calcium which is eliminated in the faeces so preventing the
absorption of dietary calcium; it similarly binds with secreted calcium preventing its reabsorption.
The diminution in calcium absorption is accompanied by a reduction in the renal excretion of
calcium and a slight increase in urinary phosphorus but the urine saturation with brushite
(CaHPC>4-2H20), a probable nidus for calcium stones, is reduced (Pak, 1973).
This paper describes some observations on the effect of sodium cellulose phosphate on intestinal
calcium uptake and urinary calcium excretion in patients with urolithiasis. Further observations
are made on the results of a limited clinical application of the substance.
Materials and Methods
Clinical Data
The effect of cellulose phosphate was evaluated in a series of patients who exhibited intestinal
hyperabsorption of calcium and hypercalciuria. All had full general and metabolic investigation
including excretion urography. Cases of overt hyperparathyroidism were excluded.
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Analytical Procedures
Intestinal calcium absorption was assessed by the technique of external radioisotope counting described in a
previous paper (Macleod, 1971). The normal range of absorption established by this method was 25% to 35%
of the calcium meal.
Urinary calcium excretion was measured with 24-hour specimens of urine by atomic absorption spectroscopy
using the Unicam SP 90. Hypercalciuria was taken as the excretion of more than 300 mg of calcium per day in the
male and more than 250 mg calcium per day in the female (Hodgkinson and Pyrah, 1958).
The serum calcium, inorganic phosphate, protein and alkaline phosphatase were estimated on at least 4 separate
occasions at the outset and at each attendance for follow-up examination with the patient in the fasting state.
Serum calcium was measured by auto-analyser using Technicon Method N3b and the upper limit of normal for
this laboratory was taken as 10-5 mg/100 ml. Serum iron, copper and magnesium were measured at the outset
in each patient and at each follow-up examination subsequently. Serum iron was measured by Richterich's method
and copper and magnesium by atomic absorption spectroscopy (Unicam SP 90).
Results
Initially the effect of sodium cellulose phosphate on 47Ca uptake was evaluated in various
conditions of dosage and administration. In the tests described in paragraphs 1 and 2 below the
sodium cellulose phosphate was taken in water within 5 minutes of an oral dose of 47Ca chloride
on the second day of an absorption test.
Laboratory Findings
1. In 10 patients who were given 5 g of the substance there was a marked reduction in 47Ca
absorption (Table I).
Table I
Effect of Cellulose Phosphate on 47Ca Absorption in Cases
Known to Absorb Calcium Excessively from the Intestine
47Ca Absorption
( 5
Subject Before CP After CP
°/ °//o /o
K. D. 70 11
T. G. H. 60 19
R. B. 58 16
E. M. F. 76 23
B. B. 67 16
T. P. 84 26
A. M. 57 18
P. G. 77 15
C. E. B. 77 18
N. J. F. 91 32
2. The dose of the substance was varied. Two cases each received 1 and 2 g respectively and
a fifth was given 3 g and then 5 g in an uptake test (Fig. 1). The effect appeared to be dose related.
Five grams reduced the intestinal calcium by as much as 85 % and even a 1 g dose resulted in a
50% reduction. The 5 g sachet provided as the standard dose therefore has a wide margin for
effective action in this respect. Such a dose, however, is probably essential when it is considered
that the substance will ordinarily be dispersed throughout a semi-solid food bolus.
Urinary calcium excretion was measured concurrently with the various dosages of sodium
cellulose phosphate and appeared to be reduced commensurately with the dose (Fig. 2).
No cellulose phosphate




Fig. 1. Effect of variable dosage of sodium cellulose phosphate on intestinal calcium
absorption.
• 1 > I I I I I I I I I | I I 1 1 1 1 1
1 2 3 4567891 2 3 4567891
Cellulose phosphate dose/g
Fig. 2. Comparison of the influence of varying dosage of sodium cellulose phosphate on
intestinal absorption and urinary excretion of calcium.
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3. The influence on calcium absorption of taking a 5 g dose of sodium cellulose phosphate at
variable intervals of time from a calcium meal was evaluated (Fig. 3).
Maximum effect was achieved if the substance was taken with a meal or within 1 hour thereafter.
There was a marked reduction in effect if the substance was taken more than 1 hour afterwards.
Bearing in mind that the calcium meal was in liquid form in these tests, it is likely that the dose
relationship of sodium cellulose phosphate to a normal meal is even more critical.
No cellulose phosphate WJM
With cellulose phosphate |^|
47CaCI2
Meal
Fig. 3. The influence of time between a calcium containing meal and dose of sodium
cellulose phosphate on the reduction of intestinal calcium absorption.
4. The effect of the substance on urinary calcium excretion was assessed in a number of patients
with hypercalciuria of varying degree (Fig. 4). In all of these, 5 g of sodium cellulose phosphate
taken 3 times daily at the time of meals, effectively reduced urinary calcium excretion to within
normal levels.
5. Other observed effects of sodium cellulose phosphate administration. Serum levels of calcium
and phosphorus were not altered in any of the patients even when the substance had been taken
for a period as long as 7 years in a dose of 5 g 3 times daily.
Since the action of sodium cellulose phosphate is not selective as regards the divalent cations
it can absorb, there is the theoretical possibility of trace metal deficiencies in long-term usage.
Dent, Harper and Parfitt (1964) found a fall of plasma magnesium from 2-0 to 1-4 mEq/1. Pak
(1973) noted a reduction in the serum concentration of magnesium and its renal excretion in a
majority of cases. He found that it did not significantly affect the metabolism of copper or zinc.
Pietrek and Kokot (1973) noted a trend towards reduction in the levels of serum magnesium,
iron, copper and zinc concentrations although this was not statistically significant.
In the present series of cases who were treated without magnesium supplement for various
periods of time there appears to have been little significant effect on plasma magnesium. One
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case treated for more than 4 years has a serum magnesium of 2-2 mg /; another treated for a
similar period, however, has a level of 1-4 mg %.
Serum copper and iron appear to have been largely uninfluenced although no statistical
evaluation of these results has been carried out. In 2 cases who have had the substance for more





Fig. 4. Effect of sodium cellulose phosphate on urinary calcium excretion in 22 cases of idiopathic hypercalciuria ad
stone formation.






Clinical Experience with Sodium Cellulose Phosphate in Recurrent Calcium Urolithiasis
All cases treated with sodium cellulose phosphate had a history of recurrent urolithiasis and were
hypercalciuric. The duration of treatment up to the present time is variable, ranging from some
months to several years.
Sodium cellulose phosphate is easy to take and is quite palatable. Intestinal upset and diarrhoea
which had been noted by others (Harrison et a!., 1972) have not been encountered.
The urinary calcium excretion has been measured in a number of patients at various intervals
of time from the commencement of treatment. In 2, hypercalciuria persisted but a subsequent
satisfactory reduction in calcium excretion has followed supplementing the treatment with a low
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Urinary calcium excretion at interval follow-up
(70%)— = 47Ca absorption
Fig. 6. Urinary calcium excretion at various intervals from commencement of treatment with
sodium cellulose phosphate.
Whilst on service p Stone passed ■ Stone removed n Stone
in the tropics H spontaneously 1 at operation u in situ
Fig. 7. Graphic representation of stone incidents in 9 cases both before and after the commencement
of sodium cellulose phosphate treatment.
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calcium diet. One of these cases had a 47Ca uptake of 70%. The majority show a satisfactory
reduction of calcium excretion to within normal rates (Fig. 6).
Pietrek and Kokot (1973) have found the urinary calcium to be maintained consistently at
reduced levels but others (Rose and Harrison, 1972) have had the impression that the initial
reduction is not maintained after a time. This is probably a measure of the tendency to default
with treatment rather than an indication of the development of resistance in some form to its
effect.
Both Pak (1973) and Pietrek and Kokot (1973) already have some evidence of a reduced
frequency of stone incidence with this treatment. The effect of the preparation in a number
of patients in this series who have been treated for several years is shown graphically (Fig. 7).
Only 2 new stones have been formed in the 9 cases depicted; in both of these there was an
additional aggravating factor of service in a tropical climate at the time of the recurrence and
both were engaged on watchkeeping duties at sea when there was difficulty in relating cellulose
phosphate dosage to irregular meals. Case P. H. has shown the most significant response; this
patient had consistently formed several stones annually from 1955 until the time of starting
treatment with sodium cellulose phosphate in 1969; the majority of stones passed had been
calcium oxalate but several were "mixed"; since the commencement of treatment there has been
no further instance of urinary colic or passage of a stone and his urinary tract is demonstrably
clear of opaque calculi at the present time, i.e. 1973. No other therapy or dietary means of
control has been adopted by this patient in the meantime. No statistical evaluation of this series
has been attempted at this time.
Discussion
Previous work (Blacklock and Macleod. 1974) has shown excessive intestinal absorption of calcium
in a significantly high proportion of calcium stone formers. In a group of apparently solitary
stone formers 76% absorbed calcium excessively. In a series of recurrent stone formers, 89%
showed excessive calcium absorption. Hypercalciuria occurred in 40 % of those with an apparently
solitary stone and in 77% of those who had formed more than one calcium stone. These findings
provide further support for a rationale of treatment directed at reducing intestinal calcium
absorption and, through this, the renal filtered load of calcium and the urinary calcium excretion.
This may be effected in whole or in part by dietary control and Nordin (1972) has described
a low calcium, low oxalate diet as the simplest and most effective regime. Dietary control, how¬
ever, whilst being an ideal form of management in a metabolic unit poses formidable day to day
difficulty to a patient and these difficulties are compounded when circumstances necessitate meals
away from home as when travelling and when feeding is institutional. In these circumstances
there is the need for an effective agent to reduce the absorption of ingested calcium. Sodium
cellulose phosphate is demonstrably effective in this respect and so far has proved innocuous. It
is considered that there is a case for its use, suitably monitored, in cases of recurrent urolithiasis
who have been shown to absorb calcium excessively from the intestine and to be hypercalciuric.
Summary
Sodium cellulose phosphate can significantly diminish the absorption of calcium from the
intestine; there is concomitant diminution of urinary calcium excretion. The plasma levels of the
divalent cations do not appear to be influenced by this therapy.
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